FDA Inspection 1073797 — Daiichi Sankyo Europe GmbH
The FDA completed an inspection of Daiichi Sankyo Europe GmbH on October 19, 2018 in Pfaffenhofen A.D.Ilm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pfaffenhofen A.D.Ilm (Germany)